Clinical Presentation, Timing, and Microbiology of CIED Infections

JACC: Clinical Electrophysiology - Tập 7 - Trang 50-61 - 2021
M. Rizwan Sohail1, G. Ralph Corey2, Bruce L. Wilkoff3, Jeanne E. Poole4, Suneet Mittal5, Charles Kennergren6, Arnold J. Greenspon7, Alan Cheng8, Jeffrey D. Lande8, Daniel R. Lexcen8, Khaldoun G. Tarakji9
1Department of Medicine and Department of Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA
2Department of Medicine, Duke Clinical Research Institute, Durham, North Carolina, USA
3Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
4Division of Cardiology, University of Washington School of Medicine, Seattle, Washington, USA
5Valley Health System, Ridgewood, New Jersey, USA
6Cardiothoracic Surgery, Sahlgrenska University Hospital, Göteborg, Sweden
7Division of Cardiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
8Cardiac Rhythm & Heart Failure (CRHF) Therapy Development and Clinical Research, Medtronic, Mounds View, Minnesota, USA
9Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA

Tài liệu tham khảo

Mond, 2011, The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project, Pacing Clin Electrophysiol, 34, 1013, 10.1111/j.1540-8159.2011.03150.x Tarakji, 2016, Cardiac implantable electronic device infection in patients at risk, Arrhythm Electrophysiol Rev, 5, 65, 10.15420/aer.2015.27.2 Greenspon, 2011, 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008, J Am Coll Cardiol, 58, 1001, 10.1016/j.jacc.2011.04.033 Wilkoff, 2020, Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT trial, Circ Arrhythm Electrophysiol, 13, 10.1161/CIRCEP.120.008503 Eby, 2020, Economic impact of cardiac implantable electronic device infections: cost analysis at one year in a large U.S. health insurer, J Med Econ, 23, 698 Baddour, 2010, Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association, Circulation, 121, 458, 10.1161/CIRCULATIONAHA.109.192665 Habib, 2015, Eur Heart J, 36, 3075, 10.1093/eurheartj/ehv319 Dai, 2019, Trends of cardiovascular implantable electronic device infection in 3 decades: a population-based study, J Am Coll Cardiol, 5, 1071 Da Costa, 1998, Role of the preaxillary flora in pacemaker infections: a prospective study, Circulation, 97, 1791, 10.1161/01.CIR.97.18.1791 David, 2012, Increasing burden of methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers, 2003-2008, Infect Control Hosp Epidemiol, 33, 782, 10.1086/666640 Le, 2012, Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species, Am J Cardiol, 110, 1143, 10.1016/j.amjcard.2012.05.052 Chua, 2000, Diagnosis and management of infections involving implantable electrophysiologic cardiac devices, Ann Intern Med, 133, 604, 10.7326/0003-4819-133-8-200010170-00011 Sohail, 2007, Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections, J Am Coll Cardiol, 49, 1851, 10.1016/j.jacc.2007.01.072 Hussein, 2016, Microbiology of cardiac implantable electronic device infections, J Am Coll Cardiol EP, 2, 498 Tarakji, 2016, Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT), Am Heart J, 180, 12, 10.1016/j.ahj.2016.06.010 Tarakji, 2019, Antibacterial envelope to prevent cardiac implantable device infection, N Engl J Med, 380, 1895, 10.1056/NEJMoa1901111 Mittal, 2020, The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: long-term follow-up, Heart Rhythm, 17, 1115, 10.1016/j.hrthm.2020.02.011 Blomstrom-Lundqvist, 2020, Eur J Cardiothorac Surg, 57, e1, 10.1093/ejcts/ezz296 Gilbert, 2012 Krahn, 2018, Prevention of arrhythmia device infection trial: the PADIT trial, J Am Coll Cardiol, 72, 3098, 10.1016/j.jacc.2018.09.068 Camus, 1993, Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal, Clin Infect Dis, 17, 46, 10.1093/clinids/17.1.46 del Rio, 2003, Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome, Chest, 124, 1451, 10.1378/chest.124.4.1451 Klug, 1997, Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management, Circulation, 95, 2098, 10.1161/01.CIR.95.8.2098 Uslan, 2007, Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study, Arch Intern Med, 167, 669, 10.1001/archinte.167.7.669 Sohail, 2014, Infections of nonvalvular cardiovascular devices, 1041 Esquer Garrigos, 2020, Molecular approach to diagnosis of cardiovascular implantable electronic device infection, Clin Infect Dis, 70, 898, 10.1093/cid/ciz266 Raad, 1997, Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group, Ann Intern Med, 127, 267, 10.7326/0003-4819-127-4-199708150-00002 Marik, 1999, The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters, Crit Care Med, 27, 1128, 10.1097/00003246-199906000-00034 Chatzinikolaou, 2003, Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study, Am J Med, 115, 352, 10.1016/S0002-9343(03)00367-X Hanna, 2004, Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial, J Clin Oncol, 22, 3163, 10.1200/JCO.2004.04.124 Leon, 2004, Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial, Intensive Care Med, 30, 1891, 10.1007/s00134-004-2378-2 Zabramski, 2003, Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial, J Neurosurg, 98, 725 Harper, 2018, Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead addition, Open Heart, 5, 10.1136/openhrt-2017-000681 George, 2020, Discriminative ability and reliability of transesophageal echocardiography in characterizing cases of cardiac device-lead vegetations versus non-infectious echodensities, Clin Infect Dis Downey, 2011, Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography, Pacing Clin Electrophysiol, 34, 679, 10.1111/j.1540-8159.2011.03034.x Mahmood, 2019, Role of (18)F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis, J Nucl Cardiol, 26, 958, 10.1007/s12350-017-1063-0 DeSimone, 2016, Management of bacteremia in patients living with cardiovascular implantable electronic devices, Heart Rhythm, 13, 2247, 10.1016/j.hrthm.2016.08.029